Authors: Kankuri, M Pelliniemi, TT Pyrhonen, S Nikkanen, V Helenius, H Salminen, E

Citation: M. Kankuri et al., Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma - A phase II study, CANCER, 92(4), 2001, pp. 761-767

Authors: Oivanen, T Ala-Harja, K Almqvist, A Apajalahti, J Elonen, E Hallman, H Hanninen, A Ilvonen, M Isomaa, B Jouppila, J Jarvenpaa, E Jarventie, G Kilpi, H Koistinen, P Koistinen, S Koivisto, AM Koivunen, E Korpi, E Katka, K Kaariainen, M Lahtinen, R Laitinen, A Lehtinen, M Makela, H Nylanden, P Nyman, D Palva, I Pelliniemi, TT Pulli, T Rajamaki, A Rauhala, A Remes, K Rosengard, S Ruutu, T Soininen, K Tiilikainen, J Timonen, T Waris, E Vilpo, J Volin, L

Citation: T. Oivanen et al., Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study, EUR J HAEMA, 65(2), 2000, pp. 123-127

Authors: Koskela, K Pelliniemi, TT Rajamaki, A Pulkki, K Remes, K

Citation: K. Koskela et al., Serum oncostatin M in multiple myeloma: impact on disease severity and prognosis, EUR J HAEMA, 65(1), 2000, pp. 52-56

Authors: Oivanen, T Ala-Harja, K Almqvist, A Apajalahti, J Elonen, E Hallman, H Hanninen, A Ilvonen, M Isomaa, B Jouppila, J Jarvenpaa, E Jarventie, G Kilpi, H Koistinen, P Koistinen, S Koivisto, AM Koivunen, E Korpi, E Katka, K Kaariainen, M Lahtinen, R Laitinen, A Lehtinen, M Makela, H Nylanden, P Nyman, D Palva, I Pelliniemi, TT Pulli, T Rajamaki, A Rauhala, A Remes, K Rosengard, S Ruutu, T Soininen, K Tiilikainen, J Timonen, T Waris, E Vilpo, J Volin, L

Citation: T. Oivanen et al., Long-term survival in multiple myeloma: a Finnish Leukaemia Group study, BR J HAEM, 105(4), 1999, pp. 942-947

Authors: Itala, M Pelliniemi, TT Remes, K Vanhatalo, S Vainio, O

Citation: M. Itala et al., Long-term treatment with GM-CSF in patients with chronic lymphocytic leukemia and recurrent neutropenic infections, LEUK LYMPH, 32(1-2), 1998, pp. 165-174